Osaic Holdings’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$275K Buy
61,200
+60,114
+5,535% +$313K ﹤0.01% 3882
2025
Q4
$6.68K Sell
1,086
-28
-3% -$203 ﹤0.01% 6543
2025
Q3
$7.3K Sell
1,114
-20
-2% -$119 ﹤0.01% 6548
2025
Q2
$6.02K Sell
1,134
-1,008
-47% -$5.95K ﹤0.01% 6439
2025
Q1
$19K Sell
2,142
-522
-20% -$6.27K ﹤0.01% 5402
2024
Q4
$36.5K Sell
2,664
-458
-15% -$8.45K ﹤0.01% 4924
2024
Q3
$85.5K Buy
3,122
+696
+29% +$18.8K ﹤0.01% 4343
2024
Q2
$59.3K Buy
2,426
+42
+2% +$922 ﹤0.01% 4537
2024
Q1
$50.8K Sell
2,384
-7,092
-75% -$152K ﹤0.01% 4746
2023
Q4
$181K Sell
9,476
-6,648
-41% -$115K ﹤0.01% 4001
2023
Q3
$259K Buy
16,124
+6,531
+68% +$124K ﹤0.01% 3806
2023
Q2
$222K Buy
9,593
+380
+4% +$8.29K ﹤0.01% 3812
2023
Q1
$214K Sell
9,213
-12,890
-58% -$262K ﹤0.01% 3816
2022
Q4
$321K Buy
22,103
+288
+1% +$5.37K ﹤0.01% 3450
2022
Q3
$417K Buy
21,815
+991
+5% +$22.7K ﹤0.01% 3066
2022
Q2
$379K Buy
20,824
+1,459
+8% +$30.3K ﹤0.01% 3210
2022
Q1
$488K Buy
19,365
+2,272
+13% +$58.1K ﹤0.01% 3244
2021
Q4
$472K Sell
17,093
-5,418
-24% -$157K ﹤0.01% 3118
2021
Q3
$726K Buy
22,511
+4,524
+25% +$150K ﹤0.01% 2648
2021
Q2
$551K Sell
17,987
-1,988
-10% -$57.4K ﹤0.01% 2926
2021
Q1
$609K Buy
19,975
+6,504
+48% +$185K ﹤0.01% 2672
2020
Q4
$266K Sell
13,471
-618
-4% -$9.98K ﹤0.01% 3220
2020
Q3
$184K Sell
14,089
-211
-1% -$2.67K ﹤0.01% 3327
2020
Q2
$162K Buy
14,300
+4,815
+51% +$68.4K ﹤0.01% 3323
2020
Q1
$136K Buy
+9,485
New +$200K ﹤0.01% 3216

Other funds holding MYGN